CTRI/2020/07/026688尚未招募未知
PHARMACEUTICAL CARE IN BREAST CANCER PATIENTS AND ITS ASSOCIATION WITH MEDICATION ADHERENCE AND QUALITY OF LIFE
Self funded0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female patients with 18 years of age and above diagnosed with breast cancer without metastasis and admitted to receive first cycle of chemotherapy.
排除标准
- •Patients who are not willing to participate in the study.
- •Mentally challenged patients
- •Patients who are not able to speak
研究者
相似试验
已完成
不适用
CHEMOTHERAPY OF MAINTENANCE IN BREAST CANCER WITHOUT HORMONE RESPONSE-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-077-03INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
招募中
不适用
Treatment of patients with breast cancer or gastrointestinal cancer and chemotherapy-induced polyneuropathia with whole body vibration (Galileo technology)Chemotherapy induced polyneuropathyG62Other polyneuropathiesDRKS00006181Klinik für Tumorbiologie50
进行中（未招募）
1 期
Cyclophosphamide chemotherapy for breast cancers harboring TP53 gene mutationsocally advanced breast cancer and metastatic breast cancerEUCTR2016-003459-31-NOHelse Bergen, Haukeland University Hospital190
未知
不适用
PIVOTAL STUDY IN PATIENTS WITH BREAST CANCER TO INVESTIGATE THE EFFICACY AND SAFETY OF LA-EP2006 and NEULASTA ®PER-119-11Sandoz GmbH,
已完成
3 期
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.sentinel lymph node metastasessentinel lymph nodes1000629110006295breast cancerNL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730